Cyclooxygenase 2 controversy: thoughts on the process of discovery, development, and assessment of benefit and risk of therapies for chronic immunoinflammatory diseases of uncertain autoimmune etiology

Arthritis Rheum. 2006 Oct 15;55(5):683-6. doi: 10.1002/art.22240.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Anti-Inflammatory Agents, Non-Steroidal / economics
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Autoimmunity / physiology
  • Chronic Disease
  • Cyclooxygenase 2 Inhibitors / adverse effects
  • Cyclooxygenase 2 Inhibitors / economics
  • Cyclooxygenase 2 Inhibitors / therapeutic use*
  • Drug Approval
  • Humans
  • Immune System Diseases / drug therapy*
  • Immune System Diseases / immunology
  • Immune System Diseases / physiopathology
  • Inflammation / drug therapy*
  • Inflammation / immunology
  • Inflammation / physiopathology
  • Risk Assessment

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase 2 Inhibitors